Skip to content

The auxiliary effect of repetitive magnetic stimulation on cognitive function in schizophrenia assessed by near-infrared imaging.

Efficacy of repetitive transcranial magnetic stimulation for cognitive dysfunction in schizophrenia: a randomized, double-blind, sham-controlled clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500107943
Enrollment
Unknown
Registered
2025-08-21
Start date
2025-09-01
Completion date
Unknown
Last updated
2025-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

schizophrenia

Interventions

active stimulation group:Receive rTMS intervention in the form of continuous 10-day, 3-times-per-day iTBS for at least 1 hour between each intervention. The stimulation site is L-DLPFC, with a stimula
sham stimulation group:We flipped the coil 180° to provide a false stimulus. The false coil can also generate a magnetic field, which participants can feel, but this magnetic field will not penetrate

Sponsors

Zigong mental health centre
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1. Meeting the diagnostic criteria for schizophrenia according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition; 2. Stable clinical status and taking antipsychotic medication: continuously taking a stable dose of antipsychotic medication for more than 4 weeks; 3. Age between 18 and 60 years; 4. MoCA score of 19-25, able to cooperate in completing the scale; 5. Right-handed.

Exclusion criteria

Exclusion criteria: 1. Presence of any significant neurological disorder; 2. Presence of mental retardation; 3. History of seizures or presence of epileptic activity on baseline electroencephalogram (EEG) (subject to evaluation by clinical EEG and epileptologist); 4. Alcohol or drug abuse within the last 3 months; 5. Depressive episodes or antidepressant treatment within the last 4 weeks; 6. History of electroconvulsive therapy (ECT); 7. Have a pacemaker, drug pump, cochlear implant, defibrillator, neurostimulator, or other metal device implanted in the body that is incompatible with rTMS; 8. Presence of severe damage to the skin surface in the area of cranial stimulation; 9. Being pregnant; 10. Presence of a serious physical illness; 11. Presence of severe positive symptoms that may interfere with the administration of cognitive tests.

Design outcomes

Primary

MeasureTime frame
The score of the Repeatable Battery for the Assessment of Neuropsychological Status;

Secondary

MeasureTime frame
The score of Positive and Negative Syndrome Scale;Changes of HBO2 and deoxyhemoglobin in near-infrared brain functional imaging;

Countries

China

Contacts

Public ContactYuke He

Zigong mental health centre

hyk6795@163.com+86 133 9843 6795

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026